We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

120 hedge funds and large institutions have $1.18B invested in Rocket Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 8

112% more capital invested

Capital invested by funds: $555M → $1.18B (+$621M)

52% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 27

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

30% more funds holding

Funds holding: 92 → 120 (+28)

0.36% less ownership

Funds ownership: 94.74% → 94.38% (-0.36%)

10% less call options, than puts

Call options by funds: $765K | Put options by funds: $846K

Holders
120
Holders Change
+28
Holders Change %
+30.43%
% of All Funds
2.36%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
36
Increased
41
Reduced
27
Closed
8
Calls
$765K
Puts
$846K
Net Calls
-$81K
Net Calls Change
+$4K

Top Buyers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$9.95M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$7.29M
3
DM
Deerfield Management
New York
+$6.52M
4
HM
HealthCor Management
New York
+$6.49M
5
FCM
Farallon Capital Management
California
+$5.91M

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$4.98M
2
CAM
Cormorant Asset Management
Massachusetts
-$4.78M
3
ACA
Avoro Capital Advisors
New York
-$3.33M
4
Bank of America
Bank of America
North Carolina
-$2.87M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.44M
Name Holding Trade Value Shares
Change 		Change in
Stake
JG
51
Jefferies Group
New York
$1.1M +$806K +48,277 New
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$1.02M -$12.2K -731 -2%
State of Wisconsin Investment Board
53
State of Wisconsin Investment Board
Wisconsin
$1.01M – – –
Federated Hermes
54
Federated Hermes
Pennsylvania
$952K +$698K +41,811 New
MIM
55
Monashee Investment Management
Massachusetts
$951K +$698K +41,800 New
WCM
56
Weld Capital Management
New York
$922K +$292K +17,491 +76%
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$853K +$11.2K +670 +2%
AllianceBernstein
58
AllianceBernstein
Tennessee
$851K -$65.1K -3,900 -9%
SSA
59
Schonfeld Strategic Advisors
New York
$829K -$654K -39,165 -52%
Barclays
60
Barclays
United Kingdom
$754K +$254K +15,195 +85%
SF
61
Synovus Financial
Georgia
$740K +$543K +32,500 New
MS
62
Maven Securities
Jersey
$729K +$518K +31,000 New
ECM
63
ExodusPoint Capital Management
New York
$707K +$308K +18,454 +146%
QSS
64
Quantitative Systematic Strategies
Florida
$705K +$209K +12,519 +68%
TIP
65
Torray Investment Partners
Maryland
$684K +$502K +30,058 New
APM
66
Avidity Partners Management
Texas
$683K +$501K +30,000 New
New York State Common Retirement Fund
67
New York State Common Retirement Fund
New York
$655K -$28.4K -1,700 -6%
Comerica Bank
68
Comerica Bank
Texas
$596K -$18.2K -1,090 -4%
FAM
69
Fred Alger Management
New York
$592K +$434K +26,000 New
HighTower Advisors
70
HighTower Advisors
Illinois
$552K +$404K +24,200 New
PPA
71
Parametric Portfolio Associates
Washington
$548K +$16.7K +998 +4%
CSS
72
Cubist Systematic Strategies
Connecticut
$513K +$376K +22,525 New
ARTA
73
A.R.T. Advisors
New York
$457K +$335K +20,075 New
WMSA
74
Weiss Multi-Strategy Advisers
New York
$455K – – –
UOC
75
UBS O'Connor
Illinois
$455K +$334K +20,000 New
1 2
3
4 5

RCKT Hedge Fund Activity: Q4 2019 in Review

120 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q4 2019, worth a combined $1.18B — up 112% from $555M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new RCKT positions and 8 closed out — a net gain of 28 holders — while 41 added to existing stakes and 27 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $9.95M. The largest seller was Sphera Funds Management, cutting an estimated $4.98M.

  • 120 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q4 2019, up from 92 in Q3 2019.
  • Funds reported $1.18B of Rocket Pharmaceuticals stock for Q4 2019, up 112% quarter-over-quarter.
  • 36 funds opened new Rocket Pharmaceuticals positions in Q4 2019 and 8 closed out, a net change of +28 holders.
  • The largest Rocket Pharmaceuticals buyer in Q4 2019 was Lord, Abbett & Co, an estimated $9.95M added.
  • The largest Rocket Pharmaceuticals seller in Q4 2019 was Sphera Funds Management, an estimated $4.98M sold.

Based on aggregated 13F filings for Q4 2019.